Finanzwire Finanzwire
Basculer en Français
11335 Companies
251957 Keywords
181304 Articles
137773 Press releases
Headlines Articles Press releases CYPRUMED GmbH Remove
  1. Home
  2. Companies
  3. CYPRUMED GmbH
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/29/2026 at 10:05, 1 month 14 days ago

    Cyprumed's Oral Delivery Technology Enters Clinical Phase with MSD Trial

    Clinical Development Phase I Trial Cyprumed Oral Delivery Technology MSD Collaboration
  • PRESS RELEASE

    published on 09/29/2026 at 10:00, 1 month 14 days ago

    Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial

    Cyprumed's oral delivery technology advances to clinical stage as MSD initiates Phase I trial, marking a significant milestone in drug development
    Phase I Trial Clinical Stage Cyprumed MSD Oral Delivery Technology
    Logo of CYPRUMED GmbH
  • BRIEF

    published on 04/15/2025 at 09:05, 1 year 6 months ago

    Cyprumed Partners with MSD on Oral Peptide Therapeutics

    Drug Delivery Technology License Agreement Cyprumed MSD Partnership Oral Peptide Therapeutics
  • PRESS RELEASE

    published on 04/15/2025 at 09:00, 1 year 6 months ago

    Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

    Cyprumed and MSD sign a Non-Exclusive License and Option Agreement for the Development of Oral Peptide Therapeutics, potentially unlocking new opportunities in peptide therapeutics
    Drug Delivery Technology License Agreement Cyprumed Oral Peptide Therapeutics MSD
    Logo of CYPRUMED GmbH
Accesswire
  • Published on 11/13/2026 at 20:15, 1 hour 38 minutes ago

    U.S. Export-Import Bank Features NioCorp's Elk Creek Critical Minerals Project in EXIM's Factory Floor Fridays Initiative

  • Published on 11/13/2026 at 18:30, 3 hours 23 minutes ago

    Sparta Capital Ltd. Announces Application to the Ontario Securities Commission to Become a Reporting Issuer in Ontario

  • Published on 11/13/2026 at 18:05, 3 hours 48 minutes ago

    Integrated BioPharma Reports Results for its Quarter Ended September 30, 2026

  • Published on 11/13/2026 at 17:25, 4 hours 28 minutes ago

    Sekur Private Data Raises SekurOne Price 25% to US$3,750 Per Year

  • Published on 11/13/2026 at 15:40, 6 hours 13 minutes ago

    Vulcan Minerals Inc. - Review and Update on Affiliated Company Atlas Salt Inc.

View all ACCESSWIRE
EQS Group
  • Published on 11/13/2026 at 19:15, 2 hours 37 minutes ago

    Increase in Equity to Accelerate Growth

  • Published on 11/13/2026 at 19:08, 2 hours 44 minutes ago

    EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026

  • Published on 11/13/2026 at 18:04, 3 hours 48 minutes ago

    EQS-Adhoc: CHAPTERS Group AG: Capital Increase from Authorized Capital Resolved

  • Published on 11/13/2026 at 17:14, 4 hours 38 minutes ago

    Issue of Equity

  • Published on 11/13/2026 at 17:00, 4 hours 52 minutes ago

    Dividend payment ex-date of Eleving Group

View all EQS
Les Echos
  • Published on 11/13/2026 at 11:35, 10 hours 17 minutes ago

    ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France

  • Published on 11/12/2026 at 23:12, 22 hours 40 minutes ago

    Belgrano continues the implementation of its public share buyback offer (OPRA)

  • Published on 11/12/2026 at 18:36, 1 day 3 hours ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026

  • Published on 11/12/2026 at 18:00, 1 day 3 hours ago

    Information concerning the total number of voting rights and shares in the share capital as of November 12, 2026

  • Published on 11/12/2026 at 17:40, 1 day 4 hours ago

    Financial information for the period ended 30 September 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy